![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
(51) | INT.CL. | A61K 9/14 | (2006.01) |
A61K 9/00 | (2006.01) | ||
A61K 9/16 | (2006.01) | ||
A61K 9/32 | (2006.01) | ||
A61K 9/36 | (2006.01) | ||
A61K 31/167 | (2006.01) | ||
A61K 31/277 | (2006.01) | ||
A61K 47/32 | (2006.01) | ||
A61K 47/38 | (2006.01) | ||
A61P 5/28 | (2006.01) | ||
A61P 13/08 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Patento numeris | 1368001 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 02712105.2 |
Europos patento paraiškos padavimo data | 2002-02-22 | |
(97) | Europos patento paraiškos paskelbimo data | 2003-12-10 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2005-10-26 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/GB2002/000766 |
Data | 2002-02-22 |
(87) | Numeris | WO 2002/067893 |
Data | 2002-09-06 |
(30) | Numeris | Data | Šalis |
0104749 | 2001-02-27 | GB | |
0102572 | 2001-07-19 | SE |
(72) |
BATEMAN, Nicola, GB
CAHILL, Julie, GB
|
(73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
(54) | PHARMACEUTICAL FORMULATION COMPRISING BICALUTAMIDE |
PHARMACEUTICAL FORMULATION COMPRISING BICALUTAMIDE |